A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Clinical trial NCT04852692 · TERMINATED

Trial details

NCT number: NCT04852692
Sponsor: Janssen Korea, Ltd., Korea
Status: TERMINATED
Study type: OBSERVATIONAL

Chronic Graft vs Host Disease

Start date: 2021-06-21
Primary completion: 2021-08-06
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.